Atlas Trials

Phase 1 Study of CH505 HIV Vaccine Nanoparticles and mRNA Boosters in Healthy Adults

Clinical trial NCT07757802 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07757802
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
HIV
Start date
2026-09-10
Primary completion
2028-06-07
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.